Sjögren's syndrome associated with erosive rheumatoid arthritis alters its prognosis and long-term therapeutic response: a case–control study

Laroche, Michel; Degboé, Yannick; Constantin, Arnaud

doi:10.1007/s00296-021-05074-0

Cited by 6 publications

(5 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It is worth noting that if there are comorbidities, such as rheumatoid arthritis with Sjogren's syndrome or ankylosing spondylitis with osteoporosis, the treatment of these comorbidities is relatively mature, and the disease outcome is good [ 37 , 38 ]. However, interdisciplinary studies on comorbidities are relatively rare, and the prognosis for patients is poor.…”

Section: Discussionmentioning

confidence: 99%

The Mechanism of “Treating Different Diseases with the Same Treatment” by Qiangji Jianpi Decoction in Ankylosing Spondylitis Combined with Inflammatory Bowel Disease: A Comprehensive Analysis of Multiple Methods

Zhang,

Zhou,

Qian

2024

Gastroenterology Research and Practice

View full text Add to dashboard Cite

Background. Ankylosing spondylitis (AS) and inflammatory bowel disease (IBD) are prevalent autoimmune disorders that often co-occur, posing significant treatment challenges. This investigation adopts a multidisciplinary strategy, integrating bioinformatics, network pharmacology, molecular docking, and Mendelian randomization, to elucidate the relationship between AS and IBD and to investigate the potential mechanisms of traditional Chinese medicine formulations, represented by Qiangji Jianpi (QJJP) decoction, in treating these comorbid conditions. Methods. We utilized databases to pinpoint common targets among AS, IBD, and QJJP decoction’s active compounds through intersection analysis. Through Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses, we mapped a network in Cytoscape, isolating critical targets. Molecular docking with AutoDock validated the affinity between targets and compounds. ROC analysis and dataset validation assessed diagnostic performance, while Gene Set Enrichment Analysis (GSEA) offered pathway insights. Mendelian randomization explored the AS-IBD causal relationship. Results. Screening identified 105 targets for QJJP decoction, 414 for AS, and 2420 for IBD, with 85 overlapping. These targets predominantly participate in organismal responses and DNA transcription factor binding, with a significant cellular presence in the endoplasmic reticulum and vesicle lumen. Molecular docking, facilitated by Cytoscape, confirmed IL1A, IFNG, TGFB1, and EDN1 as critical targets, with IFNG demonstrating diagnostic potential through GEO dataset validation. The integration of GSEA with network pharmacology highlighted the therapeutic significance of the relaxin, osteoclast differentiation, HIF-1, and AGE-RAGE signaling pathways in QJJP decoction’s action. Mendelian randomization analysis indicated a positive causal relationship between IBD and AS, pinpointing rs2193041 as a key SNP influencing IFNG. Conclusion. Based on the principle of “treating different diseases with the same method” in traditional Chinese medicine theory, we explored the intricate mechanisms through which QJJP decoction addresses AS and IBD comorbidity. Our research spotlighted the pivotal role of the IFNG gene. IFNG emerges not only as a key therapeutic target but also assumes significance as a potential diagnostic biomarker through its genetic underpinnings. This investigation establishes a solid base for subsequent experimental inquiries. Our findings introduce novel approaches for incorporating traditional Chinese medicine into the treatment of AS-IBD comorbidity, setting the stage for groundbreaking research directions.

show abstract

Section: Discussionmentioning

confidence: 99%

The Mechanism of “Treating Different Diseases with the Same Treatment” by Qiangji Jianpi Decoction in Ankylosing Spondylitis Combined with Inflammatory Bowel Disease: A Comprehensive Analysis of Multiple Methods

Zhang,

Zhou,

Qian

2024

Gastroenterology Research and Practice

View full text Add to dashboard Cite

show abstract

“…With the Sharp/van der Heijde method, Laroche et al demonstrated that the RA/SS group had more radiographic joint damage (n=39, median=15.4) compared with RA alone (n=39, me-dian=13.9). However, there was no statistical significance (p=0.79) (32). Brown et al also described the same tendency; RA/SS (n=85, median=47.5) having more radiographic joint damage than RA alone (n=744, median=17.0) (24).…”

Section: Vasmentioning

confidence: 91%

“…2A). For meta-analysis of DAS28-CRP we included 6 studies (3,24,26,28,32,33) comprising 2166 RA and 330 RA/ SS patients. We adopted a random effects model due to the high heterogeneity between studies (I2=90%, τ2=0.32, p<0.01) (Fig.…”

Section: Composite Measures Of Disease Activitymentioning

confidence: 99%

“…2B). For two papers (32,33), the mean and SD of DAS28-CRP were calculated using the provided data. These two papers showed a skewed distribution of calculated data.…”

Section: Composite Measures Of Disease Activitymentioning

confidence: 99%

“…Joint damage There were only 2 studies which included Sharp/van der Heijde scores as a measure of radiographic joint damage (24,32) and only one paper with a damaged joint count as a clinical measure (23). With the Sharp/van der Heijde method, Laroche et al demonstrated that the RA/SS group had more radiographic joint damage (n=39, median=15.4) compared with RA alone (n=39, me-dian=13.9).…”

Section: Vasmentioning

confidence: 99%

See 2 more Smart Citations

The impact of concomitant Sjögren's disease on rheumatoid arthritis disease activity: a systematic review and meta-analysis

Tomizawa,

Cox,

Kollert

et al. 2023

Clinical and Experimental Rheumatology

View full text Add to dashboard Cite

ObjectiveRheumatoid arthritis (RA) and Sjögren's syndrome (SS) frequently co-exist but the consequence for RA disease activity of having concomitant SS (RA/SS) is not well established. We conducted a systematic review and meta-analysis to investigate the impact of SS on disease outcomes in individuals with RA. MethodsWe searched Web of Science (Core Collection, FSTA, Medline), PubMed and Cochrane databases, without language restriction. Studies reporting RA disease activity scores, joint counts, visual analogue scales (VAS), disability and joint damage, and comparing RA and RA/SS were selected. Outcomes reported in at least 3 studies in which the diagnosis of SS fulfilled classification criteria underwent meta-analysis, using a random effects model where heterogeneity was detected. ResultsThe literature search identified 2991 articles and abstracts; 23 underwent full-text review and 16 were included. The studies included a total of 29722 patients (8614 with RA/SS and 21108 with RA). Using studies eligible for meta-analysis (744 patients with RA/SS and 4450 with RA), we found higher DAS-28 ESR scores (mean difference 0.50, 95% CI -0.008-1.006; p=0.05), higher swollen joint count scores (mean difference 1.05, 95% CI 0.42-1.67; p=0.001), and greater functional disability as measured by HAQ (mean difference 0.19, p=0.009) in RA/SS compared to RA alone. Other outcome measures (tender joint count, fatigue VAS) showed a numerical trend towards higher scores in RA/SS but were not statistically significant. ConclusionRA/SS patients appear to have higher disease activity and more functional disability than patients with RA alone.The aetiology and clinical implications of this are unclear and warrant further investigation.

show abstract

Neurological Impairment Caused by Rheumatoid Arthritis Complicated with Sjogren’s Syndrome Secondary to Antiphospholipid Antibody Syndrome: A Case Report and Literature Review

唐

2024

ACM

View full text Add to dashboard Cite

Sjögren's syndrome associated with erosive rheumatoid arthritis alters its prognosis and long-term therapeutic response: a case–control study

Cited by 6 publications

References 14 publications

The Mechanism of “Treating Different Diseases with the Same Treatment” by Qiangji Jianpi Decoction in Ankylosing Spondylitis Combined with Inflammatory Bowel Disease: A Comprehensive Analysis of Multiple Methods

The Mechanism of “Treating Different Diseases with the Same Treatment” by Qiangji Jianpi Decoction in Ankylosing Spondylitis Combined with Inflammatory Bowel Disease: A Comprehensive Analysis of Multiple Methods

The impact of concomitant Sjögren's disease on rheumatoid arthritis disease activity: a systematic review and meta-analysis

Neurological Impairment Caused by Rheumatoid Arthritis Complicated with Sjogren’s Syndrome Secondary to Antiphospholipid Antibody Syndrome: A Case Report and Literature Review

Contact Info

Product

Resources

About